Covered recipient · General Payments record
AHMAD ABULAWI
General Payments · PY2024–2025
$455.59
- Reported across 12 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $370.59 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $121.84 | 1 |
| Gilead Sciences, Inc. | $119.97 | 5 |
| GENZYME CORPORATION | $35.17 | 1 |
| Madrigal Pharmaceuticals | $31.78 | 1 |
| Ambu Inc. | $27.28 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.88 | 1 |
| Celltrion USA Inc. | $16.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ambu Inc. | $27.28 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207247627 | CMS |
| Celltrion USA Inc. | $16.67 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250817545 | CMS |
| GENZYME CORPORATION | $35.17 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233700733 | CMS |
| Gilead Sciences, Inc. | $23.38 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234490596 | CMS |
| Gilead Sciences, Inc. | $22.93 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234495304 | CMS |
| Gilead Sciences, Inc. | $24.99 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234474756 | CMS |
| Gilead Sciences, Inc. | $24.98 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234474876 | CMS |
| Gilead Sciences, Inc. | $23.69 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234487592 | CMS |
| Madrigal Pharmaceuticals | $31.78 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248228210 | CMS |
| Novo Nordisk Inc | $121.84 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190287823 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.88 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223839625 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.